Michigan Initial Experience Using Tigertriever for Thrombectomy
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Observational
SUMMARY
The purpose of this research study is to collect data about the effectiveness (i.e. how the device works) and safety (how safe it is to use such a device) of the Tigertriever in restoring blood flow by removing thrombus (or blood clot) from a large intracranial vessel (blood vessel in the brain) in patients experiencing ischemic stroke within 8 hours of symptom onset.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Patients admitted with large vessel occlusion (LVO) and treated with the Tigertriever, as per the approved indication.
• Tigertriever was used as the first line treatment in the target vessel.
• A signed informed consent.
• Age ≥ 18.
Locations
United States
Michigan
Henry Ford Hospital
RECRUITING
Detroit
Contact Information
Primary
Alex Chebl, MD
achebl1@hfhs.org
313-916-2644
Backup
Kelly Tundo, RN
kciach1@hfhs.org
313-916-1102
Time Frame
Start Date: 2026-01-15
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 150
Treatments
Thrombectomy Treated Patients
Patients are enrolled only if the use of the Tigertreiver is used during surgery.
Related Therapeutic Areas
Sponsors
Leads: Henry Ford Health System